| Not Yet Recruiting | Tezepelumab (Tezspire) Regulatory Postmarketing Surveillance in Korea Severe Asthma | — | 2026-11-28 |
| Not Yet Recruiting | Saphnelo Use in Females of Child-bearing Potential Systemic Lupus Erythematosus | — | 2026-10-01 |
| Not Yet Recruiting | Explore the Diagnostic Value of Bronchodilation Test With Portable Oscillometry in Asthma Diagnosis Suspected Asthma | N/A | 2026-06-30 |
| Not Yet Recruiting | Osimertinib Combined With Chemotherapy in Patients Who Had Distant Recurrence After Adjuvant Osimertinib for E Non-small Cell Lung Cancer | Phase 4 | 2026-05-31 |
| Not Yet Recruiting | A Single-arm Observational Study to Characterize the Demographic, Clinical Features and Outcomes of a Brazilia Lung Cancer | — | 2026-05-30 |
| Not Yet Recruiting | Roll-over Study for Participants Who Have Completed a Previous Clinical Study With Benralizumab (Fasenra) and Asthma, Eosinophilic Granulomatosis With Polyangiitis (EGPA), Hypereosinophilic Syndrome (HES) | Phase 3 | 2026-05-25 |
| Not Yet Recruiting | A Study to Investigate NPS and Symptoms in Chinese Adult Participants With CRSwNP Initiating Treatment With Te Chronic Rhinosinusitis With Nasal Polyps | Phase 3 | 2026-05-06 |
| Not Yet Recruiting | Implementation of Standardized Early Identification and Diagnosis for Transthyretin Amyloidosis (ATTR) in High ATTR-CM | N/A | 2026-04-30 |
| Not Yet Recruiting | A Multi-centre Chart Review Study of Stage I-III Non-Small Cell Lung Cancer in China Non-Small-Cell Lung | — | 2026-04-15 |
| Not Yet Recruiting | A Phase II Study to Investigate Lung Function With 2 Different Doses of Inhaled Glycopyrronium Taken With BFF Asthma | Phase 2 | 2026-04-15 |
| Not Yet Recruiting | A Study to Investigate the Effect of Elecoglipron on Rosuvastatin and Atorvastatin in Healthy Participants Healthy Participants | Phase 1 | 2026-04-12 |
| Recruiting | Danicopan PMS in Korea Paroxysmal Nocturnal Hemoglobinuria | — | 2026-04-10 |
| Not Yet Recruiting | Study to Evaluate the Safety and Tolerability of Camizestrant in Combination With Atirmociclib in Women With A Advanced Breast Cancer | Phase 2 | 2026-04-10 |
| Not Yet Recruiting | A Study to Assess the Effect of AZD0780 on the Pharmacokinetics of AZD4954 and Vice Versa in Healthy Adults Healthy Participants | Phase 1 | 2026-04-10 |
| Not Yet Recruiting | First-in-Human Study to Evaluate AZD8359 STEAP2 TCE in Participants With Prostate Cancer Metastatic Prostate Cancer | Phase 1 / Phase 2 | 2026-04-09 |
| Not Yet Recruiting | Surovatamig as Consolidation Therapy in Participants With Chronic Lymphocytic Leukaemia or Small Lymphocytic L Chronic Lymphocytic Leukaemia or Small Lymphocytic Lymphoma With Unmutated IGHV | Phase 3 | 2026-04-08 |
| Recruiting | Osimertinib Induction and Maintenance for Chemo-ineligible Stage III Unresectable EGFR+ NSCLC: Single-arm Stud Lung Cancer | Phase 2 | 2026-04-01 |
| Not Yet Recruiting | Ravulizumab Outcomes in Polish Patients With aHUS Atypical Hemolytic Uremic Syndrome | — | 2026-04-01 |
| Not Yet Recruiting | GYNGHER - HER2 Expression in Gynecological Malignancies: a Brazilian Cohort Gynaecological Cancers | — | 2026-04-01 |
| Not Yet Recruiting | A Study to Evaluate the Treatment Outcomes of Subcutaneous Anifrolumab in Immunosuppressant-naïve and Biologic Systemic Lupus Erythematosus | Phase 3 | 2026-04-01 |
| Recruiting | Observational Study That Will Evaluate Treatment Patterns in the Management of Hypertension in the Public Prim Hypertension | — | 2026-03-31 |
| Recruiting | A Phase I Dose Escalation and Dose Expansion Study to Investigate the Pharmacokinetics and Safety of Subcutane Solid Tumours | Phase 1 | 2026-03-31 |
| Not Yet Recruiting | A Study to Investigate the Clinical Outcome and Quality of Life in Chinese Post-operative CRSwNP Patients Chronic Rhinosinusitis With Nasal Polyps | — | 2026-03-31 |
| Recruiting | A Study to Investigate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AZD1043 in Healthy Adult Healthy Participants, Obesity | Phase 1 | 2026-03-30 |
| Recruiting | NIS to Examine Disease Activity in SLE Patients Treated With Subcutaneous Anifrolumab in Routine Care Lupus Erythematosus, Systemic | — | 2026-03-19 |
| Recruiting | A Study to Investigate the Effect of Capivasertib on the Pharmacokinetics of Oral Dextromethorphan (CYP2D6 Sub Healthy Participants | Phase 1 | 2026-03-19 |
| Recruiting | Study of AZD4956 as Monotherapy and in Combination With Anti-Cancer Agents in Participants With Advanced/Metas Solid Tumours | Phase 1 / Phase 2 | 2026-03-17 |
| Recruiting | A Phase I, Open-label, Crossover Study Comparing the Relative Bioavailability of a Fixed-Dose Combination of L Healthy Participants | Phase 1 | 2026-03-16 |
| Recruiting | A Study to Investigate the Effect of AZD5004 on Mitiglinide and Pioglitazone in Healthy Participants Healthy Participants | Phase 1 | 2026-03-13 |
| Recruiting | A Multicenter, Non-interventional, Descriptive Study to Assess Assay Concordance of HER2 IHC Testing in Chines Pan-tumor(NSCLC, GYN Cancers, BTC and UC) | — | 2026-03-06 |
| Recruiting | A Study to Investigate How Budesonide and Formoterol Move Through the Body (Pharmacokinetics) When Delivered W Asthma | Phase 1 | 2026-03-05 |
| Recruiting | A Study to Investigate the Pharmacokinetics of Different Formulations and Safety of AZD5004 in Healthy Partici Healthy Participants | Phase 1 | 2026-03-05 |
| Recruiting | CHOICE:Decision Factor of EGFR-TKI in Chinese IV NSCLC Non-Small Cell Lung Cancer | — | 2026-03-02 |
| Not Yet Recruiting | Observational Study on the Prevalence and Risk Factors of Patients With Hyperkalaemia in Brazil Hyperkalemia | — | 2026-02-28 |
| Recruiting | Phase I Study of [111In]-FPI-2107 in EGFR Mutation-positive NSCLC EGFR Mutation-positive NSCLC | Phase 1 | 2026-02-27 |
| Recruiting | A Prospecitve Multicenter, Observational Registry Study Chronic Kidney Disease | — | 2026-02-27 |
| Not Yet Recruiting | An Open-label, Single-arm Study of Prophylaxis for Datopotamab Deruxtecan (Dato-DXd) -Related Stomatitis in El Stomatitis | Phase 4 | 2026-02-27 |
| Recruiting | Lysosomal Acid Lipase Deficiency in Risk Groups Lysosomal Acid Lipase Deficiency | — | 2026-02-25 |
| Recruiting | A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics With AZD0780 Following Rep Healthy Participants | Phase 1 | 2026-02-24 |
| Recruiting | A Study Comparing AZD0120, a Dual-targeted CAR-T Against B-cell Maturation Antigen (BCMA) and CD19, Versus Sta Relapsed Refractory Multiple Myeloma | Phase 3 | 2026-02-23 |
| Recruiting | OPTIMISE-CKD Study_Dapagliflozin Effectiveness in CKD Chronic Kidney Disease | — | 2026-02-18 |
| Completed | A Study to Investigate the Concentrations of Zibotentan and Dapagliflozin in Blood When Given With and Without Healthy Participants | Phase 1 | 2026-02-16 |
| Active Not Recruiting | A Study of Absorption, Distribution, Metabolism and Excretion (ADME) of [14C]AZD4144 Healthy Participants | Phase 1 | 2026-02-11 |
| Recruiting | A Study to Investigate the Efficacy, Safety, and Tolerability of AZD4144in Participants With Sepsis-associated Sepsis, Acute Kidney Injury | Phase 2 | 2026-02-10 |
| Recruiting | Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanc Gastric Cancer, Gastroesophageal Junction Adenocarcinoma, Esophageal Cancer | Phase 3 | 2026-02-03 |
| Not Yet Recruiting | Anifrolumab Pregnancy Study Systemic Lupus Erythematosus | — | 2026-01-31 |
| Not Yet Recruiting | Phase 2 Study of Disease Risk Mutation-Guided Finite Acalabrutinib+Venetoclax for Relapsed CLL Post-1L Finite Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL) | Phase 2 | 2026-01-30 |
| Recruiting | Phase 3b Study in Patients With Severe Asthma Treated With Tezepelumab Severe Asthma | Phase 3 | 2026-01-28 |
| Recruiting | Anifrolumab Malignancy and Serious Infections Study Systemic Lupus Erythematosus | — | 2026-01-26 |
| Recruiting | Drug-drug Interaction Study With AZD5335 and Itraconazole in Participants With Ovarian, Primary Peritoneal, or Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal | Phase 1 | 2026-01-26 |
| Recruiting | A Study to Investigate Andexanet Dosing and the Interaction Between Andexanet and Subsequent Enoxaparin in Hea Healthy Participants | Phase 1 | 2026-01-19 |
| Recruiting | Prospective Registry Investigating Maternal, Infant, and Lactation Outcomes in Anifrolumab Users Systemic Lupus Erythematosus | Phase 4 | 2026-01-16 |
| Recruiting | A Study to Evaluate the Effect of AZD6793 on the Pharmacokinetics and Pharmacodynamics of Metformin in Partici Type 2 Diabetes Mellitus | Phase 1 | 2026-01-14 |
| Recruiting | A Study of AZD0120 in Autoimmune Diseases Systemic Sclerosis, Idiopathic Inflammatory Myopathies, Rheumatoid Arthritis | Phase 1 | 2026-01-09 |
| Recruiting | Study of AZD3632 Monotherapy or in Combination With Anticancer Agents in Participants With Advanced Haematolog Acute Lymphoblastic Leukaemia, Acute Myeloid Leukaemia, Higher-risk Myelodysplastic Syndromes | Phase 1 / Phase 2 | 2026-01-09 |
| Recruiting | A Phase I Study to Investigate the Pharmacokinetics and Safety of Capivasertib in Participants With Moderate H Moderate Hepatic Impairment | Phase 1 | 2026-01-06 |
| Not Yet Recruiting | A Trial to Learn How Safe AZD9750 is and How Well it Works in People With Metastatic Prostate Cancer When Give Prostate Cancer | Phase 1 / Phase 2 | 2026-01-05 |
| Recruiting | Observ Prosp Study of Acalabrutinib in CLL Therapy in Real Clinical Practice in Belarus Chronic Lymphocytic Leukemia | — | 2025-12-31 |
| Recruiting | Achievement of LLDAS5 in Patients With Systemic Lupus Erythematosus Treated With Anifrolumab. Lupus Erythematosus, Systemic | — | 2025-12-31 |
| Recruiting | The Effect of Monoallelic Variants in the ALPL Gene on the Natural Course of Hypophosphatasia in Russia Hypophosphatasia | — | 2025-12-29 |
| Recruiting | AZD5335 vs. Mirvetuximab Soravtansine in FRα-high and AZD5335 vs. Chemotherapy in FRα-low Platinum-resistant O Epithelial Ovarian Cancer | Phase 3 | 2025-12-29 |
| Recruiting | Assess Accuracy of Primary Care Asthma and COPD Diagnosis Using Oscillometry and FeNO vs Specialist Diagnosis Asthma, COPD | — | 2025-12-26 |
| Recruiting | ReAl-woRld Evaluation of tEzepelumab for Chronic rhinoSinusitis With Nasal Polyps in Russia Chronic Rhinosinusitis With Nasal Polyps (CRSwNP), Asthma | — | 2025-12-25 |
| Recruiting | Epidemiological Study of Treatment Approaches in AChR-Antibody Positive Generalized Myasthenia Gravis in Russi Rare Diseases, Generalized Myasthenia Gravis (gMG) | — | 2025-12-23 |
| Suspended | Epidemiological Study of Treatment Approaches on AQP4-IgG Positive NMOSD in Russia Rare Diseases, Neuromyelitis Optica Spectrum Disorder (NMOSD) | — | 2025-12-23 |
| Recruiting | A Real-life Observational Study in Severe Eosinophilic Asthma Adult Participant Treated With Benralizumab in I Severe Eosinophilic Asthma | — | 2025-12-20 |
| Recruiting | Study for Assessing the Prevalence of Airflow Limitation in Outpatients With History of Smoking Attending Card Respiratory (Chronic Obstructive Pulmonary Disease) | — | 2025-12-19 |
| Recruiting | Post-marketing Phase 4 Safety & Tolerability Study of Breztri aerosphereTM in Indian Patients With Chronic Obs Moderate to Severe COPD | Phase 4 | 2025-12-19 |
| Recruiting | Study of Clinical and Patient-reported Outcomes in Adults With Moderate to Severe COPD Treated With Breztri/Tr Chronic Obstructive Pulmonary Disease | — | 2025-12-15 |
| Recruiting | A Study to Investigate Efficacy and Safety of AZD1163 in Participants With Rheumatoid Arthritis Rheumatoid Arthritis | Phase 2 | 2025-12-15 |
| Active Not Recruiting | A Study to Assess the Safety, Tolerability, and Pharmacokinetics of a Single Ascending Dose of AZD0292 in Heal Healthy Participants | Phase 1 | 2025-12-12 |
| Recruiting | A Study to Investigate Safety, Tolerability, and Pharmacokinetics of AZD3974 in Healthy Participants Healthy Participants | Phase 1 | 2025-12-10 |
| Recruiting | Study of Palivizumab in Children With High Risk of Severe Respiratory Syncytial Virus (RSV) Disease Respiratory Syncytial Virus (RSV) | N/A | 2025-12-10 |
| Recruiting | Prevention of Recurrent C. Difficile Infection Study With AZD5148 Monoclonal Antibody Clostridioides Difficile Infection | Phase 2 | 2025-12-10 |
| Recruiting | An Open-label Study of AZD0120 in Adults With Multiple Sclerosis Multiple Sclerosis | Phase 1 | 2025-12-09 |
| Recruiting | A Phase IIb Study to Evaluate the Effect of Dapagliflozin in Combination With Baxdrostat Compared With Baxdros Chronic Kidney Disease and Hypertension | Phase 2 | 2025-12-05 |
| Recruiting | A Study of Rilvegostomig or Durvalumab Plus Chemotherapy for First-Line Treatment of Biliary Tract Cancer (ART Biliary Tract Cancer | Phase 3 | 2025-12-04 |
| Recruiting | Study Evaluating Safety, Tolerability, PK/PD of Surovatamig in Adult RA or SLE Participants Rheumatoid Arthritis, Systemic Lupus Erythematosus | Phase 1 | 2025-12-02 |
| Recruiting | A Study of AZD4063 in PLN R14del Dilated Cardiomyopathy Dilated Cardiomyopathy | Phase 1 | 2025-12-01 |
| Recruiting | The Eplontersen Pregnancy and Lactation Outcomes Study Transthyretin Amyloidosis | — | 2025-11-30 |
| Recruiting | The Prevalence, Disease Burden and Prognosis of COPD in Patients With Cardiovascular Diseases Cardiovascular Diseases | N/A | 2025-11-28 |
| Recruiting | Study of Patient With Frequent Exacerbations in Moscow Chronic Obstructive Pulmonary Disease (COPD) | — | 2025-11-28 |
| Recruiting | A Study to Investigate the Pharmacokinetics and Safety of Subcutaneous Rilvegostomig in Adult Participants Wit Advanced Solid Tumors | Phase 1 | 2025-11-25 |
| Recruiting | DeniLA: Comprehensive Demographics and Clinical Profile of NSCLC Patients: Analyzing Guideline-Concordant Care Lung Neoplasms | — | 2025-11-25 |
| Recruiting | A Platform Study in Non-Small Cell Lung Cancer (NSCLC) Advanced or Metastatic Non-small Cell Lung Cancer | Phase 1 / Phase 2 | 2025-11-24 |
| Recruiting | A Study to Investigate the Effect of Budesonide/Glycopyrronium/Formoterol Fumarate Metered Dose Inhaler (BGF M Chronic Obstructive Pulmonary Disease, Hyperinflation | Phase 4 | 2025-11-24 |
| Recruiting | Prevalence, Clinical Characteristics, Progression, and Management of Neurofibromatosis Type 1 in Egypt (NF1-Eg Neurofibromatosis Type 1 | — | 2025-11-19 |
| Recruiting | Durvalumab Consolidation After Chemoradiation Therapy for Limited Stage SCLC in China Limited Stage Small-Cell Lung Cancer | — | 2025-11-17 |
| Recruiting | A Study to Investigate the Effect of AZD0780 Tablets in Combination With Rosuvastatin Tablets on Low Density L Dyslipidaemia | Phase 2 | 2025-11-13 |
| Recruiting | Study of AZD4512 Monotherapy or in Combination With Anticancer Agents in Participants With Acute Lymphoblastic B-cell Acute Lymphoblastic Leukemia (B-ALL) | Phase 1 / Phase 2 | 2025-11-12 |
| Active Not Recruiting | A Study to Assess the Relative Bioavailability of Different Subcutaneous Formulations ofAZD6234 Healthy Participants | Phase 1 | 2025-11-11 |
| Recruiting | AZD0486 1L Therapy for Elderly or Unfit Participants With LBCL Large B-cell Lymphoma | Phase 3 | 2025-11-11 |
| Completed | A Study to Investigate the Effect of AZD0780 on Metformin Pharmacokinetics in Healthy Adult Volunteers Aged 18 Healthy Participants | Phase 1 | 2025-11-10 |
| Recruiting | Safety, Tolerability and Pharmacokinetics of AZD1613 in Adults With Autosomal Dominant Polycystic Kidney Disea Autosomal Dominant Polycystic Kidney Disease | Phase 1 | 2025-11-10 |
| Recruiting | The Anifrolumab PRIM Program Systemic Lupus Erythematosus | — | 2025-11-07 |
| Recruiting | A Study to Evaluate the Efficacy, Safety, and PK of AZD0292 Administered IV in Participants 12 Years of Age an Bronchiectasis With Pseudomonas Aeruginosa Colonization | Phase 2 | 2025-11-06 |
| Recruiting | A Study of AZD2962, an IRAK4 Inhibitor (IRAK4 [a Body Protein] Blocker), in Participants With Haematologic Neo Haematologic Neoplasms | Phase 1 | 2025-11-03 |
| Completed | Exacerbations and Real-World Outcomes Among Patients With Chronic Obstructive Pulmonary Disease Following Seve Chronic Obstructive Pulmonary Disease | — | 2025-10-31 |
| Recruiting | Phase III Study of Datopotamab Deruxtecan Versus Docetaxel in Previously Treated TROP2-positive Advanced or Me Non-small Cell Lung Cancer (NSCLC) | Phase 3 | 2025-10-31 |
| Recruiting | A Study of Dato-DXd in Inoperable or Metastatic Hormone Receptor-positive, HER2 IHC 0 Breast Cancer Breast Cancer | Phase 3 | 2025-10-30 |
| Completed | Understanding Non-small Cell Lung Cancer Patient Characteristics, Treatment Patterns and Outcomes Non-small Cell Lung Cancer | — | 2025-10-27 |
| Recruiting | A Translational Study for Phenotyping and Endotyping Chinese Patients With NCFBE Non-cystic Fibrosis Bronchiectasis | — | 2025-10-27 |
| Recruiting | Observational Study Evaluate Pathology Practice Use Artificial Intelligence in Patient Suspected Lung and Brea Lung Cancer, Breast Cancer | — | 2025-10-25 |
| Recruiting | CAPIVASERTIB REGULATORY POSTMARKETING SURVEILLANCE IN KOREA Breast Cancer | — | 2025-10-15 |
| Recruiting | The Burden of Atypical Hemolytic Uremic Syndrome and The Clinical Characteristics of Patients in Egyptian Hosp Atypical Hemolytic Uremic Syndrome | — | 2025-10-13 |
| Recruiting | Study of AZD0516 as Monotherapy and in Combination in Participants With Metastatic Prostate Cancer Metastatic Prostate Cancer | Phase 1 / Phase 2 | 2025-10-01 |
| Recruiting | A Study to Learn How Safe AZD6621 is, How Well it Works, and How it Moves Throughout the Body Over Time, in Ad Prostate Cancer | Phase 1 / Phase 2 | 2025-09-30 |
| Recruiting | A Phase I/II Study of AZD4512 Monotherapy or in Combination With Anticancer Agents in Participants With Relaps B-cell Non-Hodgkin Lymphoma | Phase 1 / Phase 2 | 2025-09-24 |
| Recruiting | Observational, Bi-directional (Prospective and Retrospective) Study for Patients With Newly Diagnosed Ovarian Ovarian Cancer | — | 2025-09-19 |
| Recruiting | Durvalumab With or Without Olaparib in Patients With Endometrial Cancers Regulatory Post Marketing Surveillanc Endometrial Cancer | — | 2025-09-19 |
| Recruiting | DESTINY-PANTUMOUR04 Adenocarcinoma (NOS), Anal Cancer, Bladder Cancer | — | 2025-09-18 |
| Not Yet Recruiting | LTFU for All Cell and Gene Therapy Studies Hepatocellular Carcinoma, Prostate Cancer | — | 2025-09-17 |
| Recruiting | Durvalumab After Chemoradiotherapy in Limited Stage Small Cell Lung Cancer. Small Cell Lung Carcinoma | Phase 3 | 2025-09-15 |
| Recruiting | Tezspire Cardiac Events PASS Cardiovascular Events, MACE | — | 2025-09-15 |
| Recruiting | A Study to Evaluate Acalabrutinib, in Combination With the R-CHOP Standard of Care, for Previously Untreated M Mantle-cell Lymphoma | Phase 2 | 2025-09-05 |
| Active Not Recruiting | A Phase I/II Study on Safety AND Immunogenicity of AZD4117 and AZD5315 Vaccines (PANDA) Influenza A | Phase 1 / Phase 2 | 2025-09-04 |
| Withdrawn | A Master Protocol Study to Investigate Biomarker-guided Novel Anticancer Agent(s) as Monotherapy or Combinatio Advanced/Recurrent Ovarian Cancer | Phase 1 / Phase 2 | 2025-09-02 |
| Not Yet Recruiting | Observational Study Investigating Demographic and Clinical Characteristics of SLE Patients in Egypt Systemic Lupus Erythematosus | — | 2025-08-31 |
| Not Yet Recruiting | A Multicenter Observational Study to Understand the Clinical Characteristics, Treatment Patterns and Access to Hematology, Diffused Large B Cell Lymphoma | — | 2025-08-31 |
| Withdrawn | EXACOS EG Population Chronic Obstructive Pulmonary Disease | — | 2025-08-30 |
| Active Not Recruiting | A Study to Investigate the Effects of AZD0901 Monotherapy in Adult Participants With 2L+ Advanced or Metastati Gastric Cancer, Gastroesophageal Junction Cancer | Phase 2 | 2025-08-29 |
| Completed | A Study to Evaluate the Association of Biliary Complications and Treatment Duration in Unresectable BTC Patien Biliary Tract Cancer | — | 2025-08-22 |
| Recruiting | Screening Tool Artificial Intelligence-based for Predicting the Genetic Risk of BREAST Cancer Breast Neoplasms | — | 2025-08-20 |
| Recruiting | LUNG-ROLL: Treatment Patterns and Cost of Illness of Lung Cancer in Canada Lung Neoplasms | — | 2025-08-20 |
| Recruiting | Investigation of the Effects of Renal Impairment on the Pharmacokinetics, Safety, and Tolerability of Opemalir Renal Impairment | Phase 1 | 2025-08-18 |
| Recruiting | A Study of Novel Combinations in Non-Small Cell Lung Cancer (NSCLC) Non-Small Cell Lung Cancer | Phase 2 | 2025-08-07 |
| Recruiting | A Study to Assess Efficacy and Safety of Baxdrostat in Participants With Primary Aldosteronism Primary Hyperaldosteronism | Phase 3 | 2025-08-07 |
| Recruiting | A Study of Metastases Free Survival With Saruparib vs Placebo Added to a Standard RT/ADT in Men With High-risk Prostate Cancer | Phase 3 | 2025-08-06 |
| Recruiting | Durvalumab and Tremelimumab With Lenvatinib as First-line Treatment in Patients With Unresectable Hepatocellul Hepatocellular Carcinoma | Phase 2 | 2025-08-05 |
| Recruiting | Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endo Endometrial Cancer, Malignant Solid Tumour | Phase 3 | 2025-08-01 |
| Completed | Interview of Patients With HR+/HER2- Metastatic Breast Cancer Who Received Capivasertib + Fulvestrant Metastatic Breast Cancer | — | 2025-07-31 |
| Recruiting | A Phase I, Open-label, Multicenter Study to Evaluate the Safety, Tolerability, Cellular Kinetics, Immunogenici Multiple Myeloma | Phase 1 | 2025-07-31 |
| Recruiting | A Study to Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid Tumors Melanoma, Non-small Cell Lung Cancer, Squamous Cell Carcinoma (Skin) | Phase 1 / Phase 2 | 2025-07-29 |
| Active Not Recruiting | A Study to Investigate the Efficacy and Safety of Volrustomig ± Casdatifan vs Nivolumab + Ipilimumab as 1L Tre Advanced Clear Cell Renal Cell Carcinoma | Phase 3 | 2025-07-28 |
| Completed | A Study to Investigate the Effect of Capivasertib on the Pharmacokinetics of Oral Rosuvastatin in Healthy Part Healthy Participants | Phase 1 | 2025-07-28 |
| Recruiting | A Study of Novel Agents or Combinations as Perioperative Treatment in Participants With Locally Advanced Resec Gastroesophageal Adenocarcinoma | Phase 2 | 2025-07-17 |
| Recruiting | This is a Non-interventional, Study to Assess Demographic Characteristics and Patient Reported Outcomes in Chi Chronic Obstructive Pulmonary Disease | — | 2025-07-11 |
| Recruiting | GRANITE: Airsupra Effectiveness in the Real World Asthma | — | 2025-07-09 |
| Completed | Australian Retrospective Analysis of EGFRm Advanced & Metastatic NSCLC Patients Treated With 1L or 2L Osimerti Non-small Cell Lung Cancer | — | 2025-07-04 |
| Recruiting | Prospective Registry Investigating Maternal and Infant Outcomes in Anifrolumab Users Systemic Lupus Erythematosus | — | 2025-07-01 |
| Recruiting | TReatment Approaches and bIomarkers preValence in bladdEr Cancer in RuSsian Federation Bladder Cancer | — | 2025-06-30 |
| Recruiting | Aggressive Disease Treatment Patterns and CtDNA HRR evaluatiON in High-volume metastatiC hORmone-sensitive Pro Prostate Cancer | — | 2025-06-30 |
| Withdrawn | A Study to Investigate the Sequencing Strategy of Pirtobrutinib After Disease Progression on First-line Acalab Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma | Phase 2 | 2025-06-30 |
| Recruiting | Treatment Approaches and Biomarkers PRevalence In de Novo MEtastatic Hormone-sensitive Prostate Cancer in Russ Prostate Cancer | — | 2025-06-30 |
| Recruiting | A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Chronic Obstructive Pulmonary Disease (COPD) | Phase 2 | 2025-06-27 |
| Not Yet Recruiting | A Study to Investigate the Safety and Pharmacokinetics of Single- and Multiple-ascending Doses of AZD4916 in H Healthy Participants | Phase 1 | 2025-06-27 |
| Recruiting | Hyperkalemia Quality Improvement Program (HK-QIP) Study Hyperkalemia | N/A | 2025-06-25 |
| Recruiting | Observational Study on the Clinical Profile of Patients With Uncontrolled Severe Asthma Treated With Tezepelum Asthma | — | 2025-06-25 |
| Recruiting | An Observational Study of Molecular profIling of Advanced and aggRessive ENdometrial Cancer and 1-st Line Trea Endometrial Cancer | — | 2025-06-24 |
| Completed | Characterize and Assess Clinical Outcomes of Patients Receiving Tezepelumab After Marketing Approval in Spain Asthma | — | 2025-06-23 |
| Completed | A Study of Inhaled AZD8630 in Adolescents With Asthma Asthma | Phase 1 | 2025-06-11 |
| Completed | ESPERANZA: External Control Arm Study for T-DXd for Patients With HER2 IHC3+ Solid Tumors Bladder Cancer, Biliary Tract Cancer, Cervical Cancer | — | 2025-06-10 |
| Active Not Recruiting | A Phase III Study to Assess the Effect of AZD0780 on LDL-C in Patients With HeFH Heterozygous Familial Hypercholesterolaemia | Phase 3 | 2025-06-10 |
| Recruiting | A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD4248 in Healthy Part Chronic Kidney Disease | Phase 1 | 2025-06-09 |
| Recruiting | Clinical and Demographic Characteristics of Adult p Atients With NEurofibromatosis in RUSsia Neurofibromatosis | — | 2025-06-06 |
| Recruiting | A Study to Investigate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Immunogenicity of AZD1613 Healthy | Phase 1 | 2025-06-06 |
| Recruiting | A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Cardiovascular Disease | Phase 3 | 2025-06-04 |
| Recruiting | A Study to Investigate the Effect of AZD6234, AZD9550, and a Combination of AZD9550 and AZD6234 on Pharmacokin Healthy Participants | Phase 1 | 2025-06-04 |
| Completed | Bringing Knowledge About Chronic Kidney Disease in Brazil: Filling the Gap Renal Insufficiency, Chronic | — | 2025-05-31 |
| Active Not Recruiting | A Phase III Study to Assess the Effect of AZD0780 on LDL-C in Patients With Clinical ASCVD or at Risk for a Fi Cardiovascular Disease | Phase 3 | 2025-05-28 |
| Completed | A Study to Investigate the Impact of Multiple Doses of Itraconazole on AZD5004 in Healthy Participants and Mul Healthy Participants | Phase 1 | 2025-05-28 |
| Recruiting | A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD4954 in Healthy Adul Healthy Participants, Dyslipidemia | Phase 1 | 2025-05-27 |
| Recruiting | The Phase 1, Open-label, PET Trial Designed to Investigate the Effect of AZD2389 on FAP Occupancy in the Liver Liver Fibrosis, Hepatic Cirrhosis | Phase 1 | 2025-05-26 |
| Completed | A Study in Healthy Participants to Investigate Relative Bioavailability of AZD5004 in Three Solid Oral Formula Healthy Participants | Phase 1 | 2025-05-22 |
| Terminated | A Study to Evaluate the Effect of Ceralasertib on Drug X, Drug Y and Drug Z Advanced Solid Tumours | Phase 1 | 2025-05-21 |
| Recruiting | NIS to Examine the Effectiveness and Safety of Durvalumab and Olaparib in Patients With Endometrial Cancer (DU Endometrial Cancer | — | 2025-05-20 |
| Completed | A Study Designed to Assess the Mass Balance Recovery, Absorption, Metabolism, Excretion of [14C]AZD5462 and th Heart Failure | Phase 1 | 2025-05-20 |
| Completed | A Study to Investigate the Effect of Food on Balcinrenone/Dapagliflozin Pharmacokinetics in Fed and Fasted Sta Healthy Participants | Phase 1 | 2025-05-20 |
| Recruiting | This is a Multi-centre, Multi-drug, Platform Study in Chinese Participants Living With Obesity / Overweight Obesity/Overweight | Phase 2 | 2025-05-20 |
| Recruiting | Ravulizumab Treatment Outcomes in Patients With Generalized Myasthenia Gravis Myasthenia Gravis, Generalized | — | 2025-05-15 |
| Recruiting | Perioperative Durvalumab With Neoadjuvant ddMVAC or Gemcitabine/Cisplatin in Patients With Muscle-invasive Bla Urinary Bladder Neoplasms, Immune Checkpoint Inhibitors, Methotrexate | Phase 3 | 2025-05-15 |
| Active Not Recruiting | Multicenter, Observational, Descriptive Study of the Diagnosis, Course and Treatment of Patients With SLE in R Description of SLE Activity in Patients in Routine Practice in the Republic of Kazakhstan, Description of the Course of SLE in Patients in the Republic of Kazakhstan, Description of Methods and Approaches to the Treatment of Patients With SLE in the Republic of Kazakhstan | — | 2025-05-15 |
| Completed | A Study to Investigate the Pharmacokinetics of AZD2389 in Healthy Participants When Administered Alone and in Advanced Chronic Liver Disease, Healthy Participants | Phase 1 | 2025-05-12 |
| Completed | A Study to Investigate How Multiple Oral Doses of AZD2389 Affect the Pharmacokinetics of Midazolam, Caffeine, Advanced Chronic Liver Disease, Healthy Participants | Phase 1 | 2025-05-08 |
| Recruiting | A Study to Investigate the Effects of Zibotentan/Dapagliflozin Combination Compared to Dapagliflozin Alone in Chronic Kidney Disease With High Proteinuria | Phase 2 | 2025-05-07 |
| Completed | A Study to Investigate the Effect of AZD5004 on Rosuvastatin, Atorvastatin, Simvastatin, Repaglinide and the E Healthy Participants | Phase 1 | 2025-05-06 |
| Recruiting | Phase III Study of Rilvegostomig in Combination With Bevacizumab With or Without Tremelimumab as First-line Tr Hepatocellular Carcinoma | Phase 3 | 2025-05-06 |
| Recruiting | A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD5492 in Adult Partic Systemic Lupus Erythematosus, Idiopathic Inflammatory Myopathies, Rheumatoid Arthritis | Phase 1 | 2025-05-01 |
| Recruiting | Study for AZD4360 in Participants With Advanced Solid Tumours Gastric Cancer, Gastroesophageal Junction Cancer, Biliary Tract Cancer | Phase 1 / Phase 2 | 2025-04-29 |
| Recruiting | AQUALIS:QoL of CLL Patients Treated With Acalabrutinib in France, Retrospective Study Based on Data From PLATO Chronic Lymphocytic Leukemia | — | 2025-04-28 |
| Completed | A Study to Investigate the Relative Bioavailability of 2 Different Formulations of AZD4144, the Effect of Food Healthy Participants | Phase 1 | 2025-04-23 |
| Completed | A Study to Investigate the Safety, Tolerability and Pharmacodynamics of AZD4144 in Participants With Obesity Healthy Participants | Phase 1 | 2025-04-22 |
| Recruiting | A Study to Investigate the Safety, Tolerability, and Efficacy of AZD0120 in Adults With Refractory SLE Lupus Erythematosus, Systemic | Phase 1 / Phase 2 | 2025-04-21 |
| Recruiting | Pooled Analysis of Single-arm Studies of Budesonide/Glycopyrronium/Formoterol (BGF) in Routine Care Setting Pulmonary Disease, Chronic Obstructive | — | 2025-04-17 |
| Completed | A Study to Investigate How AZD4144 Affects the Pharmacokinetics of Rosuvastatin in Healthy Participants Healthy | Phase 1 | 2025-04-17 |
| Recruiting | A Trial to Investigate Benralizumab in Children With Eosinophilic Diseases Eosinophilic Granulomatosis With Polyangiitis (EGPA), Hypereosinophilia Syndrome (HES) | Phase 3 | 2025-04-17 |
| Recruiting | Imjudo & Imfinzi PMS Hepatocellular Carcinoma | — | 2025-04-14 |
| Active Not Recruiting | A Study to Investigate Efficacy and Safety of Tozorakimab Injections Compared With Placebo in Adult Participan Chronic Obstructive Pulmonary Disease (COPD) | Phase 2 | 2025-04-12 |
| Recruiting | A Global Phase III Study of Rilvegostomig or Pembrolizumab Monotherapy for First-Line Treatment of PD-L1-high Carcinoma, Non-Small Cell Lung | Phase 3 | 2025-04-10 |
| Completed | An Accessorised Prefilled Syringe to an Autoinjector Pharmacokinetic Bridging Study of Tozorakimab Healthy Participants | Phase 1 | 2025-04-07 |
| Recruiting | AZD5305 hADME in Patients With Advanced Solid Malignancies Locally Advanced or Metastatic Solid Tumor | Phase 1 | 2025-04-02 |
| Active Not Recruiting | A Study of Volrustomig in Women With High Risk Locally Advanced Cervical Cancer (IVOLGA) Locally Advanced Cervical Cancer | Phase 2 | 2025-03-31 |
| Recruiting | Real World Study of Effectiveness of Sunitinib or Sorafenib to Chinese Unresectable Locally Advanced or Metast Papillary Renal Cell Carcinoma | — | 2025-03-31 |
| Recruiting | Randomised Clinical Trial to Investigate Efficacy and Safety of Benralizumab 30 mg SC as an add-on Therapy in Eosinophilic Asthma | Phase 3 | 2025-03-28 |
| Recruiting | First in Human Study to Evaluate AZD9793 in Participants With Advanced or Metastatic Solid Tumours Hepatocellular Carcinoma | Phase 1 / Phase 2 | 2025-03-27 |
| Recruiting | DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as Firs Endometrial Cancer | Phase 3 | 2025-03-27 |
| Recruiting | Dose Range Finding Study to Assess Efficacy and Safety of Tozorakimab in Adults With Uncontrolled Asthma on Me Asthma | Phase 2 | 2025-03-26 |
| Recruiting | A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Seve Chronic Obstructive Pulmonary Disease (COPD) | Phase 3 | 2025-03-25 |
| Active Not Recruiting | Modular Clinical Pharmacology Study to Evaluate the Drug-drug Interaction Potential and Relative Bioavailabili Advanced Solid Malignancies | Phase 1 | 2025-03-25 |
| Completed | Characterization and Clinical Outcomes of Severe Asthma Patients in Israel Treated With Benralizumab (SAIL-B) Severe Asthma | — | 2025-03-24 |
| Recruiting | A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Seve Chronic Obstructive Pulmonary Disease (COPD) | Phase 3 | 2025-03-18 |
| Not Yet Recruiting | Multinational Observational Study to Describe Diagnostic Stage Shift in Patients With Lung Cancer Using Medica Lung Cancer | — | 2025-03-15 |
| Recruiting | Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapag Heart Failure | Phase 3 | 2025-03-14 |
| Recruiting | A Study of Novel Study Interventions and Combinations in Participants With Colorectal Cancer Metastatic Colorectal Cancer | Phase 2 | 2025-03-12 |
| Active Not Recruiting | Efficacy, Safety and Tolerability of AZD6234 in Participants Living With Overweight or Obesity With Type 2 Dia Endocrinology, Diabetes, Type II, Obesity | Phase 2 | 2025-03-12 |
| Recruiting | A Phase I Study of [225Ac]-AZD2284 in Patients With Metastatic Castration-Resistant Prostate Cancer Metastatic Castration-Resistant Prostate Cancer | Phase 1 | 2025-03-10 |
| Completed | A Study to Assess the Mass Balance and ADME of [14C]AZD5004 and the Absolute Bioavailability of AZD5004 Healthy Participants | Phase 1 | 2025-03-06 |
| Recruiting | Dose-Ranging Safety, Tolerability, and Efficacy Study of AZD2373 in Participants With APOL1-Mediated Kidney Di APOL1-Mediated Kidney Disease | Phase 2 | 2025-03-05 |
| Recruiting | An Ophthalmic Safety Study in Patients With Breast Cancer Ophthalmic Safety in Patients With Breast Cancer | — | 2025-03-04 |
| Recruiting | A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdro Chronic Kidney Disease and Hypertension | Phase 3 | 2025-03-03 |
| Recruiting | A Phase Ⅲ Study of Rilvegostomig in Combination With Fluoropyrimidine and Trastuzumab Deruxtecan as the First- HER2-positive Gastric Cancer, Gastroesophageal Junction Adenocarcinoma | Phase 3 | 2025-03-01 |
| Recruiting | Anifrolumab Real-world Treatment Outcomes in Systemic Lupus Erythematosus Lupus Erythematosus, Systemic | — | 2025-02-28 |
| Completed | Study to Evaluate the Pharmacokinetics and Pharmacodynamics of AZD4604 Given Via the Turbuhaler® Device in Adu Asthma | Phase 1 | 2025-02-27 |
| Completed | A Study to Investigate the Pharmacokinetics of AZD2389 When Administered Alone and in Combination With Itracon Healthy Participants | Phase 1 | 2025-02-26 |
| Completed | Study to Investigate the Effect of Renal Impairment on the Pharmacokinetics, Safety, and Tolerability of AZD62 Renal Impairment | Phase 1 | 2025-02-24 |
| Active Not Recruiting | A Weight Loss Study Evaluating Subcutaneous Treatment With AZD9550 and AZD6234 in Combination Against Placebo Obesity or Overweight | Phase 2 | 2025-02-18 |
| Completed | A Study Evaluating the Effect of Inhaled PT007(AS MDI) Versus Placebo MDI and Ventolin Evohaler on Lung Functi Asthma | Phase 2 | 2025-02-10 |
| Active Not Recruiting | Real-life Treatment Outcomes of Ravulizumab in PNH Paroxysmal Nocturnal Haemoglobinuria | — | 2025-02-06 |
| Recruiting | Acalabrutinib Monotherapy vs Investigator's Choice of Treatment in Patients With CL Leukaemia and Heart Failur Chronic Lymphocytic Leukaemia, Heart Failure | Phase 4 | 2025-02-04 |
| Completed | A Study to Investigate the Effect of Hepatic Impairment on the Pharmacokinetics, Safety, and Tolerability of A Hepatic Impairment | Phase 1 | 2025-02-04 |
| Completed | AZAHAR Study To Describe Anifrolumab in a Real-World Setting Systemic Lupus Erythematosus (SLE) | — | 2025-02-03 |
| Recruiting | Study That Will Evaluate the Brazilian Population With COPD. COPD (Chronic Obstructive Pulmonary Disease) | — | 2025-01-31 |
| Recruiting | A Study of AZD0486 Monotherapy or in Combination With Other Anti-Cancer Agents for Mature B-Cell Malignancies Chronic Lymphocytic Leukaemia, Small Lymphocytic Lymphoma, Mantle-cell Lymphoma | Phase 1 / Phase 2 | 2025-01-30 |
| Recruiting | Real-world Study of Trastuzumab Deruxtecan in Patients With Unresectable or Metastatic HER2-low Breast Cancer Breast Cancer | — | 2025-01-29 |
| Completed | A Safety, Pharmacokinetic, and Pharmacodynamic Study of Once Daily Inhaled AZD8630 in Adults With Asthma Asthma | Phase 1 | 2025-01-28 |
| Completed | A Study to Investigate the Exposure of Budesonide, Glycopyrronium, and Formoterol (BGF) Delivered by Hydrofluo Healthy Participants | Phase 1 | 2025-01-23 |
| Recruiting | Prospective Observational Multicenter Study of Patients With AH and CKD Markers in Kazakhstan (PROGRESS-CKD) Rate of CKD Diagnosis in Patients With AH and CKD Markers, Demographic and Clinical Characteristics for Those Patients, Routine Therapy Before and After the Diagnosis of CKD | — | 2025-01-20 |
| Not Yet Recruiting | Human ADME Study of [14C]-Ceralasertib (AZD6738) and Absolute Bioavailability of Ceralasertib Neoplasm | Phase 1 | 2025-01-17 |
| Withdrawn | A Multifaceted Intervention to Improve Bleeding Management Among Patients Using Oral Anticoagulants (IMPACT-BL Bleeding | — | 2025-01-13 |
| Active Not Recruiting | A Phase IIIB Study to Evaluate the Use of Capivasertib in Combination With Fulvestrant in Patients With Advanc Locally Advanced or Metastatic Breast Cancer | Phase 3 | 2025-01-07 |
| Recruiting | Phase 4 Study to Assess the Safety of Trastuzumab Deruxtecan, in Indian Patients BREAST CANCER | Phase 4 | 2025-01-02 |
| Withdrawn | Real-life Experience in Brazil in Patients With Castration-resistant Prostate Cancer Treated With Olaparib+Abi Prostatic Neoplasms | — | 2025-01-01 |
| Recruiting | REBECCA Real-world Early BrEast CanCer mAnagement Breast Cancer | — | 2024-12-30 |
| Recruiting | A Study to Evaluate AZD7760 Safety and Pharmacokinetics in Healthy Adults (Phase I) and Adults With End-stage Staphylococcus Aureus | Phase 1 / Phase 2 | 2024-12-30 |
| Active Not Recruiting | A Study to Evaluate the Use of Durvalumab in Combination With Platinum-based Chemotherapy Followed by Durvalum Advanced or Recurrent Endometrial Cancer | Phase 3 | 2024-12-30 |
| Completed | A Study to Investigate the Pharmacokinetics, Safety, Tolerability, and Efficacy of AZD0780 With Ezetimibe Comb Dyslipidemia | Phase 1 | 2024-12-20 |
| Completed | Study to Investigate the Effect of Hepatic Impairment on the Pharmacokinetics, Safety, and Tolerability of AZD Hepatic Impairment | Phase 1 | 2024-12-19 |
| Completed | A Phase I Study to Investigate the Effect of Renal Impairment on the Pharmacokinetics, Safety, and Tolerabilit Renal Impairment | Phase 1 | 2024-12-17 |
| Active Not Recruiting | EVOLVE Study: The Real-life Clinical Practice With Tezepelumab in Greece Asthma | — | 2024-12-17 |
| Active Not Recruiting | Study of Patient With Frequent COPD Exacerbations Chronic Obstructive Pulmonary Disease (COPD) | — | 2024-12-16 |
| Recruiting | UmbREALung - A Retrospective and Prospective, Observational, Real World Multi-cohort Study of Patients With No Real World Multi-cohort Study of Patients With Non-small Cell Lung Cancer (NSCLC) Initiating Approved Drugs Developed by AZ or as Part of an AZ Alliance | — | 2024-12-16 |
| Recruiting | Study Evaluating AZD7798 for Treatment in Crohn's Disease Patients With an Ileostomy Crohn's Disease | Phase 2 | 2024-12-11 |
| Completed | A Phase 1b Study to Assess the Safety, Tolerability, and Pharmacodynamics of AZD4144 in Participants With Esta Chronic Kidney Disease, Atherosclerotic Cardiovascular Disease | Phase 1 | 2024-12-09 |
| Completed | A Study to Evaluate the Safety, Tolerability, PK, and PD Effects of AZD2389 in Participants With Liver Fibrosi Liver Fibrosis, Hepatic Cirrhosis | Phase 2 | 2024-12-06 |
| Recruiting | A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of AZD0780 in Participants With Dyslipidaemia Dyslipidaemia | Phase 2 / Phase 3 | 2024-12-06 |
| Completed | A Study to Investigate the Blood Concentrations of 4 Different Oral Doses of Zibotentan in Healthy Non-Asian a Liver Cirrhosis | Phase 1 | 2024-12-05 |
| Completed | OPTIMISE-CKD Study_current Clinical Landscape in Spain Renal Disease | — | 2024-12-04 |
| Recruiting | A Study to Investigate Changes in Symptoms in Adult Participants With Chronic Rhinosinusitis With Nasal Polypo Chronic Rhinosinusitis With Nasal Polyps | Phase 3 | 2024-12-03 |
| Completed | Observational Study on the Treatment of Patients With Metastatic Breast Cancer Cancer | — | 2024-11-30 |
| Completed | This Project Aims to Understand the Needs of Rheumatologists and Other Specialties in the Care of Patients Wit Systemic Lupus Erythematosus | — | 2024-11-29 |
| Recruiting | Surovatamig (AZD0486) as Monotherapy in Participants With Relapsed/Refractory (R/R) B-cell NHL B-cell Non-Hodgkin Lymphoma, Follicular Lymphoma (FL), Large B-Cell Lymphoma (LBCL) | Phase 2 | 2024-11-27 |
| Recruiting | A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Metas Non-squamous Non-small Cell Lung Cancer | Phase 3 | 2024-11-27 |
| Active Not Recruiting | Small/Middle Tier Cities and County Lung Cancer Quality Improvement Project (QIP) Study Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Respiratory Tract Neoplasms | — | 2024-11-22 |
| Completed | A Study to Investigate the Pharmacokinetics, Safety, and Tolerability of AZD4144 in Participants With Severe R Renal Impairment, End-stage Kidney Disease, Healthy Participants | Phase 1 | 2024-11-18 |
| Completed | A Study to Investigate the Pharmacokinetics, Safety and Tolerability of AZD5462 in Participants With Renal Imp Renal Impairment | Phase 1 | 2024-11-18 |
| Recruiting | A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Metas Non-small Cell Lung Cancer | Phase 3 | 2024-11-18 |
| Recruiting | Non-interventional Study on Guideline Directed Medical Therapy for Patients With Heart Failure (HF) in Germany Heart Disease, Heart Failure, Cardiovascular Disease | — | 2024-11-15 |
| Active Not Recruiting | An Observational, Prospective, Multicenter Study to Evaluate the Biologic Use and Outcomes in Chinese Asthma P Asthma | — | 2024-11-14 |
| Completed | VITALIZE.Use and Effectiveness of Sodium Zirconium Cyclosilicate (LokelmaTM) in the Real-world Setting in Spai Hyperkalaemia | — | 2024-11-13 |
| Active Not Recruiting | Boosting Regional Integration for COP D Care Through Guided Implementation and Audit of Post Exacerbation Tran COPD | — | 2024-11-13 |
| Completed | Covid-19 Data Analyses in Brazil Covid | — | 2024-11-12 |
| Completed | A Study to Investigate Multiple Ascending Doses of AZD5004 in Healthy Japanese Participants and Participants W Healthy Participants, Type 2 Diabetes | Phase 1 | 2024-11-02 |
| Completed | A Study to Investigate the Pharmacokinetics of Ethinyl Estradiol and Levonorgestrel When Given Alone and in Co Healthy Participants | Phase 1 | 2024-11-01 |
| Completed | Safety and Tolerability of AZD5148 in Japanese Participants Clostridioides Difficile Infection | Phase 1 | 2024-10-31 |
| Completed | A Study to Assess the Effect of AZD0780 on Ambulatory Blood Pressure Atherosclerotic Cardiovascular Disease | Phase 2 | 2024-10-30 |
| Recruiting | INTERSTELLAR - International Study Evaluating Lupus Outcomes After Anifrolumab Real World Use Systemic Lupus Erythematosus (SLE) | — | 2024-10-22 |
| Completed | Pharmacokinetic and Safety Study of Subcutaneous and Intravenous Anifrolumab Delivered in Healthy Adult Partic Healthy Volunteers | Phase 1 | 2024-10-21 |
| Completed | A Phase I PK Study of Balcinrenone/Dapagliflozin in Healthy Chinese Participants Healthy Volunteer | Phase 1 | 2024-10-21 |
| Terminated | A Phase I/IIa Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of AZD0022 as Mono Advanced Solid Tumours, Non-Small Cell Lung Cancer (NSCLC), Pancreatic Ductal Adenocarcinoma (PDAC) | Phase 1 | 2024-10-18 |
| Completed | Establish FeNO Cut-off Value for Predicting Budesonide-formoterol Response in Chronic Cough Suggestive of CVA Cough-Variant Asthma | Phase 4 | 2024-10-18 |
| Withdrawn | A Study to Assess the Lung Exposure Bioequivalence of Budesonide, Glycopyrronium, & Formoterol (BGF) Metered D Healthy | Phase 1 | 2024-10-17 |
| Completed | Positron Emission Tomography Study of Changes in [11C]AZ14132516 Uptake Following Administration of AZD7798 to Crohn Disease | Phase 1 | 2024-10-16 |
| Terminated | AZD3427 Effects on Renal Perfusion in Heart Failure Patients With Reduced Ejection Fraction and Renal Impairme Heart Failure With Reduced Ejection Fraction (HFrEF), Renal Impairment | Phase 1 | 2024-10-15 |
| Active Not Recruiting | A Phase III, Randomised Study of Adjuvant Dato-DXd in Combination With Rilvegostomig or Rilvegostomig Monother Non-small Cell Lung Cancer | Phase 3 | 2024-10-15 |
| Completed | Effects of AZD5004 in Adults Who Are Living With Obesity or Overweight With at Least 1 Weight-related Comorbid Obesity or Overweight | Phase 2 | 2024-10-08 |
| Completed | Efficacy, Safety, and Tolerability of Once Daily Oral Administration of AZD5004 Versus Placebo for 26 Weeks in Diabetes Mellitus, Type 2 | Phase 2 | 2024-10-08 |
| Recruiting | A Study to Investigate the Efficacy and Safety of Dato-DXd With or Without Osimertinib Compared With Platinum Metastatic Non-small Cell Lung Cancer | Phase 3 | 2024-10-04 |
| Completed | A Study in Participants With Obesity or Overweight With at Least One Weight-related Comorbidity Obesity or Overweight | Phase 2 | 2024-10-01 |
| Recruiting | A Pan-European Post-Authorisation Safety Study: Risk of Pancreatic Cancer Among Type 2 Diabetes Patients Who I Pancreatic Cancer | — | 2024-09-30 |
| Active Not Recruiting | Open-label Study to Assess Reduction of Background Asthma Medication While Sustaining Asthma Control and Clini Severe Asthma | Phase 3 | 2024-09-30 |
| Terminated | A Phase Ib Study of AZD5462 on Top of Dapagliflozin in Participants With Heart Failure and Moderate Renal Impa Renal Impairment, Heart Failure | Phase 1 | 2024-09-27 |
| Active Not Recruiting | A Study in Patients With Myasthenia Gravis in China Myasthenia Gravis | — | 2024-09-26 |
| Active Not Recruiting | Capivasertib+Fulvestrant asTreatment for Locally Advanced(Inoperable) or Metastatic HR+/HER2- Breast Cancer in Breast Cancer | Phase 3 | 2024-09-26 |
| Completed | An Open-label Study in Healthy Participants to Evaluate AZD0780 as an Object or Precipitant of CYP3A4-mediated Dyslipidaemia | Phase 1 | 2024-09-25 |
| Active Not Recruiting | A Study to Investigate the Effects of Durvalumab With Oleclumab Following Chemoradiation in Participants With Non-Small Cell Lung Cancer | Phase 2 | 2024-09-24 |
| Recruiting | A Study to Evaluate Safety, PK, PD and Efficacy of AZD5492, a T Cell-engaging Antibody Targeting CD20 in Subje B-cell Malignancies | Phase 1 / Phase 2 | 2024-09-18 |
| Active Not Recruiting | Chronicling the COPD Patient Journey and Change in COPD Symptoms, Quality of Life and Exacerbations Following Chronic Obstructive Pulmonary Disease (COPD) | — | 2024-09-17 |
| Completed | Study to Investigate Changes in Airway Inflammation, Symptoms, and Rescue Therapy Utilization With AIRSUPRA Co Mild Asthma | Phase 4 | 2024-09-11 |
| Active Not Recruiting | Real-world Study Assessing Efficacy of TezepeLumaB in Patients With Severe Asthma Regardless of Phenotype in R Severe Asthma | — | 2024-09-10 |
| Completed | A Dose Range-Finding Study to Assess the Efficacy and Safety of Multiple Dose Levels of AZD8630 in Adults With Asthma | Phase 2 | 2024-08-30 |
| Completed | Clinical and Demographic Features of Patients With Moderate to Severe Active Systemic Lupus Erythematosus in R Systemic Lupus Erythematosus | — | 2024-08-30 |
| Active Not Recruiting | Phase IIa Study Evaluating AZD7798 in Crohn's Disease Moderate to Severe Crohn's Disease | Phase 2 | 2024-08-28 |
| Recruiting | Volrustomig Priming Regimens Exploratory Phase II Platform Study Non-small Cell Lung Cancer | Phase 2 | 2024-08-27 |
| Completed | A Study to Investigate the Pharmacokinetics of Midazolam After Repeated Doses of Camizestrant (AZD9833) and to Healthy Participants | Phase 1 | 2024-08-27 |
| Active Not Recruiting | A Study of Dapagliflozin in Chinese Adult Patients With Chronic Kidney Disease Chronic Kidney Disease | Phase 4 | 2024-08-23 |
| Recruiting | Study of Volrustomig as Monotherapy or in Combination With Anti- Cancer Agents in Participants With Advanced/M Sub-study 1 Cervical Cancer (Volrustomig Monotherapy), Sub-study 2 Head and Neck Squamous Cell Carcinoma (Volrustomig Monotherapy), Sub-study 3 Head and Neck Squamous Cell Carcinoma (Volrustomig in Combination With Chemotherapy) | Phase 2 | 2024-08-22 |
| Completed | Phase I PK Study of Budesonide/Albuterol Delivered From PT027 in Healthy Chinese Participants. Healthy Volunteer | Phase 1 | 2024-08-19 |
| Completed | A Study to Investigate Multiple Ascending Doses and Relative Bioavailability of AZD5004 in Healthy Participant Healthy Participants | Phase 1 | 2024-08-15 |
| Completed | EXACERBATIONS AND REAL-WORLD OUTOMES AMONG PATIENTS WITH COPD INITIATING BREZTRI (EROS+CP Japan Study) Pulmonary Disease, Chronic Obstructive | — | 2024-08-15 |
| Recruiting | Phase 3 Study of T-DXd and Rilvegostomig Versus SoC in Advanced HER2-expressing Biliary Tract Cancer Biliary Tract Cancer | Phase 3 | 2024-08-12 |
| Completed | Study to Investigate the Effect of Hepatic Impairment on the Pharmacokinetics, Safety, and Tolerability of AZD Hepatic Impairment | Phase 1 | 2024-08-08 |
| Recruiting | A Study of Surovatamig (AZD0486) Plus Rituximab in Previously Untreated Follicular Lymphoma Patients Untreated Follicular Lymphoma | Phase 3 | 2024-08-07 |
| Completed | A Study to Assess the PK, PD, Safety and Tolerability of Eplontersen in Healthy Chinese Volunteers Transthyretin-mediated Amyloidosis | Phase 1 | 2024-08-06 |
| Completed | A Study to Investigate the Relative Bioavailability of AZD8630 Following a Device and Formulation Transition i Healthy Participants | Phase 1 | 2024-08-06 |
| Completed | A Study to Investigate the Effect of Oral Ticagrelor on the Pharmacokinetics of Oral Rosuvastatin When Given i Healthy Participants | Phase 1 | 2024-08-05 |
| Completed | Phase II Study to Evaluate the Effect of AZD4604 on Airway Inflammation and Biomarkers in Adults With Asthma Asthma | Phase 2 | 2024-08-05 |
| Completed | A Single and Multiple Ascending Dose Study to Investigate the Safety, Tolerability, and Pharmacokinetics of AZ Healthy Participants | Phase 1 | 2024-08-02 |
| Withdrawn | A Study of Andexanet Alfa in Patients Requiring Urgent Surgery or Procedure Urgent Surgery | Phase 3 | 2024-08-02 |
| Completed | A Phase I Study to Investigate the Effect of Renal Impairment on the Pharmacokinetics, Safety, and Tolerabilit Renal Impairment | Phase 1 | 2024-08-02 |
| Recruiting | Saruparib (AZD5305) Plus Camizestrant Compared With CDK4/6 Inhibitor Plus Endocrine Therapy or Plus Camizestra Advanced Breast Cancer | Phase 3 | 2024-08-01 |
| Recruiting | A Phase 1, Dose-escalation Study of [225Ac]-FPI-2068 in Adult Patients With Advanced Solid Tumours Advanced Solid Tumor, Metastatic Colorectal Carcinoma, Head and Neck Squamous Cell Carcinoma | Phase 1 | 2024-07-31 |
| Completed | REAL-WORLD DURVALUMAB IN EXTENSIVE-STAGE SMALL CELL LUNG CANCER Small Cell Lung Carcinoma | — | 2024-07-30 |
| Recruiting | RACE-2L: Real-World Assessment of Clinical Practice and Outcomes in Non-squamous NSCLC After Failure of Platin Non-squamous Non-Small Cell Lung Cancer | — | 2024-07-25 |
| Recruiting | A Non-interventional, Prospective Study With Benralizumab Asthma, Bronchial | — | 2024-07-25 |
| Completed | A Study to Assess the Pharmacokinetics of AZD6793 When Administered Alone and in Combination With Itraconazole Healthy Participants | Phase 1 | 2024-07-23 |
| Active Not Recruiting | Osimertinib With Chemotherapy as First-line Therapy for EGFR Mutation-positive NSCLC Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Respiratory Tract Neoplasms | — | 2024-07-23 |
| Active Not Recruiting | A Study to Investigate the Effect on Lung Function of BDA Formulated With a Next Generation Propellant Compare Asthma | Phase 3 | 2024-07-22 |
| Recruiting | Study of Acalabrutinib and Rituximab in Untreated Elderly and/or Frail Patients With DLBCL Diffuse Large B-Cell Lymphoma | Phase 2 | 2024-07-16 |
| Recruiting | Fasenra Pediatric Japan Post-Marketing Study(PMS) Bronchial Asthma | — | 2024-07-16 |
| Completed | A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of Inhaled AZD4604 in Healthy Japanese a Healthy Participants | Phase 1 | 2024-07-15 |
| Completed | A Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD4144 as Well as the I Healthy Participants | Phase 1 | 2024-07-15 |
| Completed | FAITH - Factor XA Inhibitor-Related InTracranial Haemorrhage InTracranial Haemorrhage | — | 2024-07-08 |
| Completed | Real-World Outcomes in COPD Patients Starting Trixeo (Budesonide/Glycopyrronium/Formoterol) in Spain. Chronic Obstructive Pulmonary Disease (COPD) | — | 2024-07-02 |
| Recruiting | A Phase III Study to Investigate the Efficacy and Safety of Anifrolumab in Adults With Chronic and/or Subacute Cutaneous Lupus Erythematosus | Phase 3 | 2024-06-29 |
| Recruiting | NIS to Examine the Effectiveness of TDC in Patients With Metastatic Non-squamous NSCLC and High-risk Genetic A Non-squamous Metastatic Non-Small-Cell Lung Carcinoma | — | 2024-06-28 |
| Recruiting | Clinical& Demographic Profiles of patIents With unControllEd Asthma in Russia: Multi-center oBsErvational ReGi Uncontrolled Asthma | — | 2024-06-27 |
| Recruiting | Non-interventional Study of Patients With Transthyretin (ATTR) Amyloidosis Transthyretin Amyloidosis, ATTR-CM, ATTRv-PN | — | 2024-06-25 |
| Completed | A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of AZD5148 in Healthy Adults Healthy Participants | Phase 1 | 2024-06-24 |
| Recruiting | A Study to Investigate the Efficacy and Safety of Anifrolumab Administered as Subcutaneous Injection and Added Polymyositis, Dermatomyositis | Phase 3 | 2024-06-20 |
| Recruiting | Prevalence of Emerging Treatment-induced Mutations in Metastatic ER-positive Breast Cancer. Metastatic Breast Cancer | — | 2024-06-17 |
| Completed | Observational Retrospective Study To Characterize and Assess Clinical Outcomes of Patients Receiving Tezepelum Severe Asthma | — | 2024-06-17 |
| Recruiting | A Study to Investigate Efficacy and Safety of PT027 Compared With PT007 in Symptomatic Chinese Adults With Ast Asthma | Phase 3 | 2024-06-17 |
| Recruiting | Real-World Treatment Study of Koselugo (Selumetinib) Neurofibromatosis 1, Neurofibroma, Plexiform | — | 2024-06-15 |
| Completed | A Study to Evaluate Cortisol Reserve in Response to Adrenocorticotropic Hormone (ACTH) Stimulation Test Follow Uncontrolled Hypertension | Phase 2 | 2024-06-10 |
| Recruiting | Clinical and demOgRaphic Features of Patients With Uncontrolled Severe Asthma in Russia (CORSAR) Severe Asthma | — | 2024-06-06 |
| Recruiting | A Translational Study for Prediction of Biomarkers and Identification of Phenotype and Endotype of COPD and Ea COPD | — | 2024-06-05 |
| Completed | A Phase IIb Study of AZD5462 in Patients With Chronic Heart Failure Chronic Heart Failure | Phase 2 | 2024-06-04 |
| Completed | EXACERBATIONS AND REAL-WORLD OUTOMES INCLUDING CARDIOPULMONARY EVENTS AMONG PATIENTS WITH CHRONIC OBSTRUCTIVE Pulmonary Disease, Chronic Obstructive | — | 2024-05-31 |
| Completed | Real-World Treatment Study of Soliris (Eculizumab) Observational | — | 2024-05-28 |
| Recruiting | Evaluating the Efficacy and Safety of PT027 Compared With PT007 Administered As Needed in Participants 12 to < Asthma | Phase 3 | 2024-05-20 |
| Completed | A Study to Investigate the Safety and Pharmacokinetics of AZD6793 in Healthy Japanese and Chinese Participants Healthy Participants | Phase 1 | 2024-05-15 |
| Completed | UNFOLD Study Egypt Breast Cancer | — | 2024-05-13 |
| Terminated | Drug-Drug Interaction and Safety of AZD4041 Study (Part 1) and Efficacy, Safety, Pharmacokinetics and Pharmaco Opioid Use Disorder | Phase 1 | 2024-05-13 |
| Active Not Recruiting | Combination Short-Acting BroNchodilator and Inhaled Corticosteroid Rescue Therapy on Health Outcomes in Routin Asthma | Phase 4 | 2024-05-10 |
| Completed | Long-Term Organ Damage: Anifrolumab Versus Real-World Standard of Care in Adult Patients With Active Systemic Long-Term Organ Damage in Adult Patients With Active Systemic Lupus Erythematosus | — | 2024-05-09 |
| Terminated | REACT - REAl Care for AsThma - A Disease Study to Identify Patients With Severe Uncontrolled Asthma Asthma, Bronchial | — | 2024-05-07 |
| Completed | Study to Investigate the Effect of Hepatic Impairment on the Pharmacokinetics, Safety, and Tolerability of Bal Hepatic Impairment | Phase 1 | 2024-05-02 |
| Completed | Efficacy, Safety and Tolerability of Balcinrenone/Dapagliflozin Compared to Dapagliflozin in Adults With Chron Chronic Kidney Disease | Phase 2 | 2024-05-01 |
| Completed | Change in Patient-repOrted Outcomes in COPD Patients Newly Initiated on TRIXEO AEROSPHERE in Real worlD Chronic Obstructive Pulmonary Disease (COPD) | — | 2024-04-30 |
| Completed | A Study to Assess the Pharmacokinetics and Safety of Budesonide, Glycopyrronium, & Formoterol (BGF) Metered Do Chronic Obstructive Pulmonary Disease | Phase 1 | 2024-04-29 |
| Completed | Assessment of Safety of Olaparib in Chinese Patients With Ovarian Cancer in the Real-World Setting Using NCID Database to Assess the Safety of Olaparib in Chinese Patients With Ovarian Cancer by Examining the Incidence, Seriousness, and Severity of All AE | — | 2024-04-29 |
| Recruiting | Phase III, Open-label Study of First-line Osimertinib With or Without Datopotamab Deruxtecan for EGFRm Locally Non-small Cell Lung Cancer | Phase 3 | 2024-04-29 |
| Active Not Recruiting | Real-world Study on Dapagliflozin Usage in Patients With Heart Failure (HF) in Germany Heart Diseases, Cardiovascular Diseases, Heart Failure | — | 2024-04-25 |
| Completed | NIS Study Determining Prevalence of HER2-low in Metastatic Breast Cancer Patients HER2-negative | — | 2024-04-23 |
| Completed | HER-TEMPO - Real World Treatment-related Outcomes on T-DXd in Canada Unresectable Breast Cancer, Metastatic Breast Cancer, HER2-low Expressing Breast Cancer | — | 2024-04-22 |
| Completed | C.Difficile Observational Study Clostridium Infections | — | 2024-04-22 |
| Completed | Patient Characteristics, Treatment Patterns and Outcomes of Patients With Severe Asthma Treated With Tezepelum Severe Asthma | — | 2024-04-22 |
| Active Not Recruiting | To Evaluate the Efficacy/Safety of Osimertinib Prior to CRT and Maintenance of it With Stage III, Unresectable Lung Cancer | Phase 2 | 2024-04-21 |
| Completed | A Study to Investigate the Pharmacokinetics of Baxdrostat When Given Alone and in Combination With Itraconazol Healthy Participants | Phase 1 | 2024-04-16 |
| Completed | Brazilian Reality of Hepatocellular Carcinoma Hepatocellular Carcinoma, Hepatocellular Carcinoma by BCLC Stage, Hepatocellular Carcinoma Stage I | — | 2024-04-15 |
| Recruiting | Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Heart Failure and Impaired Kidney Function | Phase 3 | 2024-04-12 |
| Completed | A Positron-emission Tomography Study to Determine Brain Exposure of [11C]Savolitinib in Healthy Volunteers Healthy Volunteers | Phase 1 | 2024-04-12 |
| Recruiting | Phase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanced Non-squamou Non-Small Cell Lung Cancer | Phase 3 | 2024-04-11 |
| Completed | A Study to Assess the Safety, Tolerability, and Pharmacokinetics of a Single Ascending Dose of AZD0292 In Heal Healthy Participants Study | Phase 1 | 2024-04-09 |
| Completed | A Study to Investigate Relative Bioavailability of Two Different Dosage Forms for Tozorakimab Via Subcutaneous Healthy Participants | Phase 1 | 2024-04-08 |
| Active Not Recruiting | A Study to Investigate the Efficacy and Safety of Baxdrostat in Participants With Uncontrolled Hypertension on Uncontrolled Hypertension, Resistant Hypertension | Phase 3 | 2024-04-08 |
| Active Not Recruiting | A Study to Investigate the Efficacy of Durvalumab Plus Tremelimumab in Combination With Chemotherapy Compared Carcinoma, Non-Small-Cell Lung | Phase 2 | 2024-04-04 |
| Terminated | A Study to Investigate Safety, Tolerability, and Pharmacokinetics of Oral AZD0233 Compared With Placebo in Hea Dilated Cardiomyopathy | Phase 1 | 2024-04-01 |
| Active Not Recruiting | A Phase III Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin on CK Chronic Kidney Disease and Hypertension | Phase 3 | 2024-03-29 |
| Completed | A Study To Evaluate The Treatment Pattern Of Moderate-to-Severe Asthma Patients In China Moderate-to-Severe Asthma | — | 2024-03-22 |
| Recruiting | Phase 1 Study to Investigate TCRTs KRAS Mutation in Unresectable, Advanced, and/or Metastatic Solid Tumors Non-small Cell Lung Cancer, Colorectal Carcinoma, Pancreatic Ductal Adenocarcinoma | Phase 1 | 2024-03-22 |
| Active Not Recruiting | Treatment and Biomarker Testing Patterns,Treatment Outcomes in a/m NSCLC With and Without Actionable Genomic A Non-small-cell Lung Cancer | — | 2024-03-20 |
| Completed | Efficacy of FDC Regimen of Dapagliflozin/Metformin Compared to Co-administered Dual Therapy on Glycemic Contro Type 2 Diabetes Mellitus (T2DM) | Phase 4 | 2024-03-15 |
| Recruiting | An Efficacy and Safety Study of Intravenous Anifrolumab to Treat Systemic Lupus Erythematosus in Pediatric Par Systemic Lupus Erythematosus | Phase 3 | 2024-03-14 |
| Completed | PROPE Severe Asthma Study in Egypt Severe Asthma | — | 2024-03-12 |
| Recruiting | Study of AZD0754 in Participants With Metastatic Prostate Cancer Metastatic Prostate Cancer | Phase 1 / Phase 2 | 2024-03-12 |
| Completed | HER2 TREAT Study: Retrospective Study to Estimate the Prevalence of HER2-low in Unresectable and/or Metastatic Breast Neoplasms, Breast Cancer, Breast Carcinoma | — | 2024-03-05 |
| Recruiting | AZD0901 Compared With Investigator's Choice of Therapy in Participants With Second- or Later-line Advanced or Gastric Cancer, Gastroesophageal Junction Cancer | Phase 3 | 2024-03-04 |
| Completed | A Study to Investigate the Effect of Baxdrostat on Ambulatory Blood Pressure in Participants With Resistant Hy Resistant Hypertension | Phase 3 | 2024-03-01 |
| Completed | A Study to Investigate the Effect on QTcF of Baxdrostat Compared With Placebo, Using Moxifloxacin as a Positiv Healthy Participants | Phase 1 | 2024-02-29 |
| Completed | A Comparative Effectiveness Study of Mortality Outcomes and Related Cardiopulmonary Events Among a Cohort of C Pulmonary Disease, Chronic Obstructive | — | 2024-02-29 |
| Active Not Recruiting | STEP: Phase IIIb Study of Benralizumab to Step-down Maintenance Therapy in Patients With Severe Eosinophilic A Severe Eosinophilic Asthma | Phase 3 | 2024-02-28 |
| Completed | A Retrospective Chart Review to Investigate Clinical Remission in Patients With Severe Asthma Treated With Bio Asthma | — | 2024-02-27 |
| Active Not Recruiting | Study to Assess Neoadjuvant Durvalumab (D) and Platinum-Based Chemotherapy (CT), Followed by Either Surgery an Non-small Cell Lung Cancer | Phase 2 | 2024-02-22 |
| Recruiting | A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on COPD (Chronic Obstructive Pulmonary Disease) | Phase 3 | 2024-02-21 |
| Recruiting | A Study of T-DXd as Monotherapy or in Combination With Anti-cancer Agents in Patients With Selected HER2-expre Advanced Solid Tumors (Excluding Gastric Cancer and Breast Cancer) | Phase 2 | 2024-02-18 |
| Completed | An ADME Study of [14C]AZD4604 and the Absolute Bioavailability of AZD4604 Asthma | Phase 1 | 2024-02-16 |
| Completed | A Phase IIb Study to Evaluate the Safety of Zibotentan/Dapagliflozin in Participants With Cirrhosis-ZEAL-UNLOC Liver Cirrhosis | Phase 2 | 2024-02-15 |
| Recruiting | Real-World Clinical Experience of Patients With Metastatic Castration-Resistant Prostate Cancer Treated With O Metastatic Castration-resistant Prostate Cancer | — | 2024-02-14 |
| Active Not Recruiting | A US Study to Evaluate Transarterial Radioembolization (TARE) in Combination With Durvalumab and Bevacizumab T Hepatocellular Carcinoma (HCC) | Phase 2 | 2024-02-13 |
| Completed | A National, Multicenter, Prospective, Observational Study to Assess Patient Characteristics, Treatment Algorit Hyperkalaemia | — | 2024-02-09 |
| Completed | A Study to Evaluate the Consistency of Oscillometry and Spirometry Test Results in Patients With Confirmed or Asthma/ COPD | — | 2024-02-08 |
| Active Not Recruiting | Study of AZD9829 in CD123+ Hematological Malignancies Hematological Malignancies | Phase 1 / Phase 2 | 2024-01-31 |
| Recruiting | AZD3470 as Monotherapy and in Combination With Anticancer Agents in Participants With Relapsed/Refractory Haem Lymphoma, Non-Hodgkin, Hodgkin Lymphoma | Phase 1 / Phase 2 | 2024-01-23 |
| Completed | A Study to Assess the Efficacy, Safety and Tolerability of Different Doses of AZD0780 in Patients With Dyslipi Dyslipidemia | Phase 2 | 2024-01-19 |
| Withdrawn | IKANOS: Breztri Maintenance Versus Any Non-Triple Inhaled Therapy After Hospitalization for a COPD Exacerbatio COPD | Phase 4 | 2024-01-19 |
| Recruiting | A Study of AZD3470, a PRMT5 Inhibitor, in Patients With MTAP Deficient Advanced/Metastatic Solid Tumors Advanced Solid Tumors That Are MTAP Deficient | Phase 1 / Phase 2 | 2024-01-18 |
| Active Not Recruiting | A Real-World Assessment of the Demographic, Clinical Characteristics and Outcomes of a Brazilian Cohort of Pre Extensive-stage Small-cell Lung Cancer | — | 2024-01-18 |
| Active Not Recruiting | A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD1705 in Participants Cardiovascular | Phase 1 | 2024-01-16 |
| Active Not Recruiting | A Prospective, Non-interventional, Observational Study of Presentation, Treatment Patterns and Outcomes in Aty Atypical Hemolytic Uremic Syndrome(aHUS) | — | 2024-01-15 |
| Recruiting | PRospectIve ObseRvatIonal mulTicenter Study of Patients With Arterial hYpertension and CKD in the Population o Arterial Hypertension, Chronic Kidney Disease | — | 2024-01-15 |
| Completed | A Study to Investigate the Effect on Lung Function of an Approved COPD Treatment (BGF, With HFA Propellant) Co COPD (Chronic Obstructive Pulmonary Disease) | Phase 3 | 2024-01-11 |
| Completed | A Study to Assess Multidomain Endpoints of an ECG Patch Acute Decompensated Heart Failure | — | 2024-01-08 |
| Recruiting | A Translational Study to Describe Clinical Characteristics, Biomarkers and to Identify Phenotypes and Endotype Asthma | — | 2024-01-08 |
| Terminated | Study of Non-Small Cell Lung Cancer Patients in the US Receiving Standard-of-Care and Initiating an Approved T Non-Small Cell Lung Cancer | — | 2024-01-05 |
| Completed | MultIceNtre Non-intERVentional Study for Efficacy,Safety Evaluation of BREZTRI in Pts With COPD in RussiA Chronic Obstructive Pulmonary Disease | — | 2023-12-29 |
| Completed | Hereditary Transthyretin Amyloidosis Polyneuropathy in Patients With Carpal Tunnel Syndrome in Russia Hereditary Transthyretin Amyloidosis, Carpal Tunnel Syndrome, Polyneuropathy | — | 2023-12-29 |
| Recruiting | AZD0486 as Monotherapy in B-cell Acute Lymphoblastic Leukaemia B-cell Acute Lymphoblastic Leukemia (B-ALL) | Phase 1 / Phase 2 | 2023-12-29 |
| Completed | hATTR Polyneuropathy in Russia Hereditary Transthyretin Amyloidosis | — | 2023-12-29 |
| Terminated | Transthyretin Amyloidosis Cardiomyopathy in Patients With HFpEF in Russia Transthyretin Amyloidosis Cardiomyopathy, Heart Failure With Preserved Ejection Fraction | — | 2023-12-28 |
| Completed | A Study to Investigate the Effects of PT027 (Budesonide/Albuterol Sulfate) Metered-dose Inhaler Compared With Asthma, Exercise-Induced | Phase 3 | 2023-12-22 |
| Active Not Recruiting | Observational Study to Evaluate the Effect and Safety of Selumetinib in Pediatric Patients With NF1-PNs Neurofibroma, Plexiform | — | 2023-12-20 |
| Completed | Observational Secondary Data Study Describing Treatment With Dapagliflozin Among Adult Chronic Kidney Disease Chronic Kidney Disease (CKD) | — | 2023-12-20 |
| Completed | TrinetX Study of Hypereosinophilic Syndrome (HES) Without an Identifiable Non-haematological Secondary Cause Hypereosinophilic Syndrome (HES) | — | 2023-12-15 |
| Recruiting | A Global Study of Volrustomig (MEDI5752) for Participants With Unresected Locally Advanced Head and Neck Squam Locally Advanced Head and Neck Squamous Cell Carcinoma | Phase 3 | 2023-12-14 |
| Active Not Recruiting | A Phase I/II Study to Evaluate AZD5851 in GPC3+ Advanced/Recurrent Hepatocellular Carcinoma Hepatocellular Carcinoma | Phase 1 / Phase 2 | 2023-12-14 |
| Active Not Recruiting | REAl-world Outcomes in CHronic Lymphocytic Leukemia Patients Receiving Acalabrutinib in Romania Chronic Lymphocytic Leukemia | — | 2023-12-13 |
| Recruiting | AZD0901 in Participants With Advanced Solid Tumours Expressing Claudin18.2 Gastric Cancer, Gastroesophageal Junction Cancer, Biliary Tract Cancer | Phase 2 | 2023-12-13 |
| Active Not Recruiting | A Study of Acalabrutinib Plus Venetoclax and Rituximab in Participants With Treatment Naïve Mantle Cell Lympho Mantle Cell Lymphoma (MCL) | Phase 2 | 2023-12-13 |
| Completed | An Observational Study to Describe EVUSHELD™ (Tixagevimab/Cilgavimab) Pre-exposure Prophylaxis in Real-world S COVID-19 | — | 2023-12-06 |
| Recruiting | A First-in-human Dose Escalation and Expansion Study to Evaluate the Safety, and Tolerability of AZD8421 Alone ER+ HER2- Advanced Breast Cancer, High-grade Serous Ovarian Cancer (HGSOC) | Phase 1 / Phase 2 | 2023-12-05 |
| Recruiting | AZD0305 as Monotherapy or in Combination With Anticancer Agents in Participants With Relapsed/Refractory Multi Multiple Myeloma | Phase 1 / Phase 2 | 2023-12-05 |
| Completed | A Study to Describe the Characteristics, Health Care Interventions and Outcomes of Patients With Major Bleedin Major Bleeding | — | 2023-12-04 |
| Active Not Recruiting | Rilvegostomig + Chemotherapy as Adjuvant Therapy for Biliary Tract Cancer After Resection (ARTEMIDE-Biliary01) Biliary Tract Cancer | Phase 3 | 2023-12-04 |
| Terminated | Trastuzumab-deruxtecan in Patients With Triple-negative Metastatic HER2-Low Breast Cancer: Real-world Experien Breast Cancer | — | 2023-12-04 |
| Active Not Recruiting | EPIC-ATTR: A Study to Evaluate the Effect of Eplontersen on the Transthyretin Reduction and Long-term Safety i Transthyretin Amyloid Cardiomyopathy | Phase 3 | 2023-12-01 |
| Active Not Recruiting | Chronic Kidney Disease Registry Platform Study Chronic Kidney Diseases | — | 2023-11-28 |
| Completed | A Randomized Trial Evaluating a mRNA-VLP Vaccine's Immunogenicity and Safety for COVID-19 COVID-19, SARS-CoV-2 Infection | Phase 1 | 2023-11-27 |
| Recruiting | A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy i Breast Cancer | Phase 3 | 2023-11-23 |
| Terminated | Non-alcoholic Steatohepatitis Registry Platform Study NASH With Fibrosis | — | 2023-11-22 |
| Completed | A Study to Investigate the Efficacy and Safety of Baxdrostat in Participants With Uncontrolled Hypertension on Uncontrolled Hypertension, Resistant Hypertension | Phase 3 | 2023-11-22 |
| Recruiting | Saruparib (AZD5305) vs Placebo in Men With Metastatic Castration-Sensitive Prostate Cancer Receiving Physician Metastatic Castration-Sensitive Prostate Cancer | Phase 3 | 2023-11-21 |
| Completed | A Single and Multiple Ascending Dose Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmaco Healthy Participants | Phase 1 | 2023-11-20 |
| Completed | Study to Assess the Pharmacokinetic Bioequivalence of Budesonide and Albuterol With an Alternate Propellant Co Heathy Participants | Phase 1 | 2023-11-16 |
| Completed | Phase 2a Study to Assess the Efficacy and Safety of AZD4604 in Adult Patients With Moderate-to-Severe Asthma U Asthma | Phase 2 | 2023-11-16 |
| Completed | A Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics of Subcutaneous AZD6912 in Heal Rheumatoid Arthritis | Phase 1 | 2023-11-15 |
| Active Not Recruiting | A Phase III Randomised Study to Evaluate Dato-DXd and Durvalumab for Neoadjuvant/Adjuvant Treatment of Triple- Breast Cancer | Phase 3 | 2023-11-14 |
| Completed | A Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD6234 After Repeat Dos Healthy Participants | Phase 1 | 2023-11-13 |
| Completed | A Real-world, Multi-center, Prospective, Observational Study for PNH in China Paroxysmal Nocturnal Hemoglobinuria | — | 2023-11-10 |
| Recruiting | MEDI5752 in Combination With Carboplatin Plus Pemetrexed in Unresectable Pleural Mesothelioma Unresectable Pleural Mesothelioma | Phase 3 | 2023-11-09 |
| Active Not Recruiting | Determine Effectiveness of Anifrolumab In SYstemic Sclerosis (DAISY) Systemic Sclerosis, Scleroderma | Phase 3 | 2023-11-08 |
| Active Not Recruiting | Study to Investigate Efficacy, Safety, and Tolerability of Zibotentan/Dapagliflozin Compared to Dapagliflozin Chronic Kidney Disease With High Proteinuria | Phase 3 | 2023-11-07 |
| Completed | A Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD4144 Following Single Healthy Participants | Phase 1 | 2023-11-07 |
| Completed | A Placebo-controlled Safety and Tolerability Study of Intravenous (IV) and Subcutaneous (SC) AZD1163 in Health Healthy Volunteers | Phase 1 | 2023-11-01 |
| Completed | Retrospective Medical Chart Review Study to Describe the Experience of SLE Patients Treated With Anifrolumab i Systemic Lupus Erythematosus | — | 2023-10-27 |
| Completed | A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of AZD7503 in Japanese Healthy Participa Heathy Participants | Phase 1 | 2023-10-25 |
| Completed | A Study to Evaluate the Effect of Budesonide, Glycopyrronium, Formoterol Fumarate (BGF) Metered Dose Inhaler ( Chronic Obstructive Pulmonary Disease | Phase 3 | 2023-10-24 |
| Active Not Recruiting | A Global Study of Volrustomig (MEDI5752) Plus Chemotherapy Versus Pembrolizumab Plus Chemotherapy for Particip Metastatic Non-small Cell Lung Cancer | Phase 3 | 2023-10-24 |
| Recruiting | PRostate Olaparib Real World Evidence Study Metastatic Castration-resistant Prostate Cancer | — | 2023-10-11 |
| Completed | Retrospective Study on Characteristics and Outcomes in Hospitalised Patients Treated With Ondexxya Hemorrhage | — | 2023-10-06 |
| Recruiting | An Adjuvant Endocrine-based Therapy Study of Camizestrant (AZD9833) in ER+/HER2- Early Breast Cancer (CAMBRIA- Breast Cancer, Early Breast Cancer | Phase 3 | 2023-10-05 |
| Active Not Recruiting | A Trial to Learn How Safe AZD9550 Monotherapy and Combined With AZD6234 is in People With or Without Type 2 Di Overweight and Obesity | Phase 1 / Phase 2 | 2023-09-29 |
| Completed | Study Will Assess the Safety, Neutralizing Activity and Efficacy of AZD3152 in Adults With Conditions Increasi COVID-19, SARS-CoV-2 | Phase 2 | 2023-09-29 |
| Completed | The Prevalence Evaluation of Systemic Lupus Erythematosus in Russian Patients With Reproductive Issues (PRISMA Systemic Lupus Erythematosus | — | 2023-09-28 |
| Completed | Tezepelumab PRO Study Asthma | — | 2023-09-27 |
| Completed | Positron Emission Tomography (PET) Study of Changes in [11C]AZ14132516 Uptake Following Administration of AZD7 Crohn's Disease | Phase 1 | 2023-09-25 |
| Recruiting | Study of Volrustomig in Women With High Risk Locally Advanced Cervical Cancer (eVOLVE-Cervical) Locally Advanced Cervical Cancer | Phase 3 | 2023-09-22 |
| Active Not Recruiting | Efficacy and Safety of Tozorakimab in Symptomatic Chronic Obstructive Pulmonary Disease With a History of Exac Chronic Obstructive Pulmonary Disease (COPD) | Phase 3 | 2023-09-22 |
| Recruiting | A Study to Investigate the Biological Effects of Saruparib (AZD5305), Darolutamide, and in Combination in Men Prostate Cancer | Phase 1 | 2023-09-21 |
| Recruiting | PROVIDENCE - Prospective Non-interventional Study (NIS) to Examine Patient-reported Outcomes and Real-world Cl Breast Neoplasms, Breast Cancer, Neoplasm Metastasis | — | 2023-09-12 |
| Completed | Real-World Treatment Patterns and Patient Reported Outcome in COPD (REMIND) COPD | — | 2023-09-11 |
| Withdrawn | Selumetinib in Chinese Paediatric With Post-operative NF1-PNs, PhaseⅡ, Double-Blinded, Placebo-Controlled Stud Neurofibromatosis Type 1, Plexiform Neurofibromas, Post-operative | Phase 2 | 2023-08-31 |
| Recruiting | A Study to Investigate the Efficacy and Safety of Tezepelumab Compared With Placebo in Children 5 to < 12 Year Asthma | Phase 3 | 2023-08-24 |
| Recruiting | OverTTuRe: Characteristics, Treatment Patterns and Outcomes of Patients With ATTR Amyloidosis ATTR Amyloidosis | — | 2023-08-21 |
| Active Not Recruiting | Durvalumab With Chemotherapy as First Line Treatment in Patients With Advanced Biliary Tract Cancers (aBTCs) Biliary Tract Cancer | Phase 3 | 2023-08-16 |
| Active Not Recruiting | BCG in Combination With Durvalumab in Adult BCG-naïve, High-risk NMIBC Participants Non-Muscle- Invasive Bladder Cancer | Phase 3 | 2023-08-11 |
| Completed | eVusheld Assessment reaL wORld Effectiveness in DoD Health System COVID-19; SARS-CoV-2; 2019 Novel Coronavirus Disease | — | 2023-08-10 |
| Active Not Recruiting | Acalabrutinib Real World Italian obSErvational Study -ARISE Chronic Lymphocytic Leukemia | — | 2023-08-08 |
| Completed | Study of AZD3152 Intramuscular Injection or Intravenous Infusion in Healthy Japanese Adult Participants COVID-19, SARS-CoV-2 | Phase 1 | 2023-07-31 |
| Completed | A Study to Identify and Characterise Patients With Chronic Kidney Disease and Proteinuria Renal Disease | — | 2023-07-31 |
| Recruiting | OSIREAL - Osimertinib RWE on EGFRm NSCLC in Spain Non-small Cell Lung Cancer | — | 2023-07-28 |
| Completed | Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD5055 in Japanese and Chinese Healthy Volun Healthy Participants | Phase 1 | 2023-07-27 |
| Completed | A Study to Assess Safety, Pharmacokinetics Anti-Drug Antibody and Anti-RSV Antibody After 2 Doses of Nirsevima Respiratory Syncytial Virus Infections | Phase 3 | 2023-07-27 |
| Completed | Secondary Data Analysis of Patients at Risk for CKD to Inspect CKD Prevalence, Diagnosis Rates, Diagnostic Beh Chronic Kidney Diseases | — | 2023-07-26 |
| Completed | Real-world, 52-week Prospective Study to Capture the Reasons for Switch to Triple Combination Therapy, Assess Pulmonary Disease, Chronic Obstructive (COPD) | — | 2023-07-21 |
| Completed | A Phase 3b, Open-label, Multi-center Study on Durvalumab in Combination With Gemcitabine-based Chemotherapy as Biliary Tract Cancers | Phase 3 | 2023-07-21 |
| Recruiting | AZD0120 in Relapsed/Refractory Multiple Myeloma (DURGA-1) Relapsed/Refractory Multiple Myeloma | Phase 1 / Phase 2 | 2023-07-20 |
| Active Not Recruiting | A Study to Investigate Safety and Efficacy of Osimertinib and Amivantamab in Participants With Non-small Cell Non-Small Cell Lung Cancer (NSCLC) | Phase 2 | 2023-07-18 |
| Completed | Brazilian Reality in the Diagnosis and Treatment of Diffuse Large B Cell Lymphoma - BRA-DLBCL Diffuse Large B Cell Lymphoma | — | 2023-07-15 |
| Recruiting | A Study of NT-175 in Adult Subjects With Unresectable, Advanced, and/or Metastatic Solid Tumors That Are Posit Non-small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma, Colorectal Carcinoma | Phase 1 | 2023-07-12 |
| Active Not Recruiting | PICAROS - Acalabrutinib RWE on 1L CLL in Spain Chronic Lymphocytic Leukemia | — | 2023-07-11 |
| Recruiting | Study of AZD5863 in Adult Participants With Advanced or Metastatic Solid Tumors Gastric Cancer, Gastro-esophageal Junction Cancer, Pancreatic Ductal Adenocarcinoma | Phase 1 / Phase 2 | 2023-07-11 |
| Completed | Brazilian Reality of Urinary Bladder Cancers - BRA-BLADDER Urothelial Carcinoma, Non Muscle Invasive Bladder Cancer, Muscle-invasive Bladder Cancer | — | 2023-07-10 |
| Completed | A Study to Characterize the Outcomes of Olaparib Maintenance Monotherapy in Newly Diagnosed BRCAwt Ovarian Can Advanced Ovarian Cancer | — | 2023-07-10 |
| Terminated | An Observational Study of Patients Receiving T-DXd for Treatment of HER2+, and HER2-low Unresectable and/or Me Breast Cancer | — | 2023-07-07 |
| Active Not Recruiting | A Non-interventional Prospective Study of Early HER2-negative High-risk Breast Cancer and BRCA1/2 Mutations Pr Breast Cancer | — | 2023-06-30 |
| Active Not Recruiting | Durvalumab and Tremelimumab as First Line Treatment in Participants With Advanced Hepatocellular Carcinoma (HC Advanced Hepatocellular Carcinoma | Phase 3 | 2023-06-27 |
| Completed | To Determine the Accuracy of SCreening for Occult REnal Disease (SCORED) Questionnaire for CKD Risk Among Asia Chronic Kidney Disease | — | 2023-06-22 |
| Active Not Recruiting | A Non-interventional Prospective Study of 1-st Line Treatment Approaches in OVArian Cancer Patients With HRD+ Ovarian Cancer | — | 2023-06-21 |
| Active Not Recruiting | A Study to Investigate Efficacy and Safety of Ceralasertib Plus Durvalumab in Participants Aged ≥ 18 Years Wit Advanced or Metastatic NSCLC | Phase 2 | 2023-06-21 |
| Completed | Calquence CLL 1L Japan PMS _ Japan Post-Marketing Surveillance (PMS) Study Previously Untreated Chronic Lymphocytic Leukaemia (Including Small Lymphocytic Lymphoma) | — | 2023-06-19 |
| Completed | A Phase I Study to Investigate the Effect of Hepatic Impairment on the PK, Safety, and Tolerability of AZD2693 Hepatic Impairment | Phase 1 | 2023-06-16 |
| Completed | Study to Assess Effect of Next-Generation Propellant MDI on Mucociliary Clearance Vs. HFA Propellant MDI in He Mucociliary Clearance | Phase 3 | 2023-06-14 |
| Completed | Imfinzi BTC Japan PMS_Japan Post-Marketing Surveillance (PMS) Study - CEI/SCEI Biliary Tract Cancer | — | 2023-06-06 |
| Recruiting | Phase I/IIa Study of AZD5335 as Monotherapy and Combination Therapy in Participants With Solid Tumors Ovarian Cancer, Lung Adenocarcinoma, Endometrial Cancer | Phase 1 / Phase 2 | 2023-06-05 |
| Completed | Imfinzi/Imjudo NSCLC Japan PMS_Japan Post-Marketing Surveillance (PMS) Study - CEI/SCEI Carcinoma, Non-Small-Cell Lung | — | 2023-06-02 |
| Completed | A Study to Assess the Effects of Fluvoxamine on Savolitinib Exposure in Healthy Male Subjects Healthy Male Subjects | Phase 1 | 2023-06-02 |
| Completed | Outcomes in Real-life After Initation of Treatment With Trixeo (Budesonide / Glycopyrronium / Formoterol) Chronic Obstructive Pulmonary Disease | — | 2023-06-01 |
| Completed | HER2(Human Epidermal Growth Factor Receptor 2) -Positive Metastatic Breast Cancer in Russia Breast Cancer | — | 2023-05-31 |
| Completed | HER2-low Unresectable and/or Metastatic Breast Cancer in Russia Breast Cancer | — | 2023-05-30 |